Boston Scientific Corp (FRA:BSX)
€ 38.95 +0.17 (+0.43%) Market Cap: 58.43 Bil Enterprise Value: 67.05 Bil PE Ratio: 18.73 PB Ratio: 2.57 GF Score: 74/100

Boston Scientific Corp at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 02:10 PM GMT
Release Date Price: €63.6 (-1.55%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BSX.N - Boston Scientific Corp
Boston Scientific Corp at TD Cowen Healthcare Conference
Mar 03, 2026 / 02:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
We've got Chairman, President, CEO Mike Mahoney, and Chief Medical Officer Doctor Ken Stein, here in Boston with the TD Cow team.

Thank you. Good morning. Can you hear us?

Thank you guys. That, that's coming through nicely. Well, wanted to kick it off and just ask about, just, you've walked through this on the 4th quarter call at the investor day last year, just, this 10% plus growth guidance you issued 10 to 11% on the fourth quarter earnings call. It looks very similar to the starting point of 2025 where you guys were at 10 to 12%. Maybe just discuss what's different this year compared to last year as you see it and speak about your confidence about maintaining this, these high double-digit rates of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot